ArticleJournal of ovarian research2015

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.

Kai-Xuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.